Using their GGE, Hypersynth Life Sciences activates these silent genes via precise promoter engineering. Their lead candidate, , has shown efficacy against WHO-listed critical priority pathogens, including carbapenem-resistant Acinetobacter baumannii . In murine models, HS-7 demonstrated a "lysis time" of 15 minutes—four times faster than colistin.
Operating out of the , the company is positioned directly within India's primary pharmaceutical hub. This proximity grants immediate access to high-grade raw feedstocks, certified testing laboratories, and specialized transport networks. This infrastructure ensures the company can fulfill domestic and international orders efficiently. hypersynth life sciences
Beyond pharma, Hypersynth Life Sciences has a dedicated environmental division. They recently unveiled (Polyethylene Extremophile Rapid Fusion). This enzyme cocktail, when sprayed on PET plastic, breaks it down into terephthalic acid and ethylene glycol in under 24 hours at room temperature. This solves the single biggest economic hurdle of recycling: energy cost. Using their GGE, Hypersynth Life Sciences activates these
As the biotechnology industry continues to evolve, companies like Hypersynth Life Sciences will play a critical role in shaping the future of healthcare, agriculture, and environmental sustainability. With its cutting-edge platform and innovative products and technologies, Hypersynth Life Sciences is well-positioned to make a significant impact in the years to come. Operating out of the , the company is
